Catalio Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-389,384
Closed -$3.97M 44
2025
Q1
$3.97M Sell
389,384
-17,908
-4% -$182K 0.97% 22
2024
Q4
$6.45M Buy
+407,292
New +$6.45M 1.41% 23